(Q33349260)

26 July 2017

1 reference

title

Management of heparin-induced thrombocytopenia: a critical comparison of lepirudin and argatroban (English)

1 reference

heparin-induced thrombocytopenia

26 July 2017

1 reference

1 reference

1 reference

1

Theodore E Warkentin

1 reference

26 July 2017

language of work or name

1 reference

1 May 2003

1 reference

26 July 2017

1 reference

26 July 2017

volume

110

1 reference

26 July 2017

issue

2-3

1 reference

26 July 2017

page(s)

73-82

1 reference

Heparin‐induced thrombocytopenia: pathogenesis and management

26 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2803%2900336-0

7 January 2021

Venous limb gangrene during overlapping therapy with warfarin and a direct thrombin inhibitor for immune heparin-induced thrombocytopenia

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2803%2900336-0

7 January 2021

An improved definition of immune heparin-induced thrombocytopenia in postoperative orthopedic patients

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2803%2900336-0

7 January 2021

Temporal aspects of heparin-induced thrombocytopenia

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2803%2900336-0

7 January 2021

Heparin-induced thrombocytopenia in patients treated with low-molecular-weight heparin or unfractionated heparin

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2803%2900336-0

7 January 2021

Central venous catheters and upper-extremity deep-vein thrombosis complicating immune heparin-induced thrombocytopenia

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2803%2900336-0

7 January 2021

The incidence of heparin-induced thrombocytopenia in hospitalized medical patients treated with subcutaneous unfractionated heparin: a prospective cohort study

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2803%2900336-0

7 January 2021

A 14-year study of heparin-induced thrombocytopenia

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2803%2900336-0

7 January 2021

Failure of early heparin cessation as treatment for heparin-induced thrombocytopenia

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2803%2900336-0

7 January 2021

Argatroban anticoagulant therapy in patients with heparin-induced thrombocytopenia.

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2803%2900336-0

7 January 2021

Argatroban anticoagulation in patients with heparin-induced thrombocytopenia

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2803%2900336-0

7 January 2021

Recombinant hirudin (lepirudin) provides safe and effective anticoagulation in patients with heparin-induced thrombocytopenia: a prospective study

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2803%2900336-0

7 January 2021

Lepirudin (recombinant hirudin) for parenteral anticoagulation in patients with heparin-induced thrombocytopenia. Heparin-Associated Thrombocytopenia Study (HAT) investigators.

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2803%2900336-0

7 January 2021

Argatroban therapy does not generate antibodies that alter its anticoagulant activity in patients with heparin-induced thrombocytopenia

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2803%2900336-0

7 January 2021

The pathogenesis of venous limb gangrene associated with heparin-induced thrombocytopenia

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2803%2900336-0

7 January 2021

Venous limb gangrene during warfarin treatment of cancer-associated deep venous thrombosis

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2803%2900336-0

7 January 2021

Safety of warfarin anticoagulation in patients with heparin-induced thrombocytopenia

1 reference

https://api.crossref.org/works/10.1016%2FS0049-3848%2803%2900336-0

7 January 2021

10.1016/S0049-3848(03)00336-0

Identifiers

DOI

1 reference

26 July 2017

1 reference